Express News | Corvus Pharmaceuticals Announces Publication In Science Signaling Demonstrating ITK Inhibition By Soquelitinib Induces Anti-Inflammatory Treg Cells; Study Highlights Potential For Treating Inflammatory Autoimmune And Allergic Diseases
Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Stock Price Dropped 12% Last Week; Retail Investors Would Not Be Happy
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
13 Penny Stocks With Insider Buying in 2024
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Express News | Steven Cohen Reports 9.9% Passive Stake in Corvus Pharmaceuticals Inc as of May 2 - SEC Filing
Corvus Pharmaceuticals | 10-Q: Quarterly report
Corvus Pharmaceuticals Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
Express News | Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q1 Financial Results
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer
Express News | Corvus Pharmaceuticals : Oppenheimer Raises Target Price to $8 From $7
Express News | Oppenheimer Maintains Outperform on Corvus Pharma, Raises Price Target to $8
Corvus Pharma Analyst Ratings
Express News | Corvus Pharmaceuticals - Issue and Sell to Investors in Registered Direct Offering Aggregate of 13.5 Mln Shares of Common Stock, Among Others
Express News | Corvus Pharmaceuticals Inc - Entry Into a Material Definitive Agreement
Express News | Corvus Pharma Expects FY24 Net Cash Used In Operating Activities ~$24M-$27M, Resulting In Projected Cash Balance Of $31M-$34M At Dec. 31, 2024; Expects Cash To Find Operations Into Q4 2025
Express News | Corvus Pharmaceuticals: Recent Financing Gives US Runway Through Several Expected Clinical Readouts for Pipeline in 2024 and 2025
Express News | Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results